Fatigue associated with multiple sclerosis: diagnosis, impact and management

Multiple Sclerosis Journal - Tập 9 Số 3 - Trang 219-227 - 2003
Rohit Bakshi1
1Buffalo Neuroimaging Analysis Center and William C Baird Multiple Sclerosis Research Center, The Jacobs Neurological Institute, University at Buffalo, State University of New York, Buffalo, New York, USA,

Tóm tắt

In patients with multiple sclerosis (MS) fatigue is the most common symptom and one of the most disabling features. A s many as 40% have described it as the single most disabling symptom - a higher percentage than weakness, spasticity, motor problems, or bowel or bladder problems. The etiology and patho physiology of MS-related fatigue remain unknown. Studies have failed to demonstrate an association between MS-related fatigue and the level of disability, clinical disease subtype, or gender, although recent data show an association between MS-related fatigue and depression and quality of life. Imaging studies using positron emission tomography suggest that fatigue in MS is related to hypometabolism of specific brain areas, including the frontal and subcortical circuits. The impact of fatigue on patient functioning and quality of life clearly warrants intervention. In addition to nonpharmacologic measures, such as exercise and energy conservation strategies, several pharmacologic agents have been evaluated for their ability to reduce MS-related fatigue, including amantadine, central nervous system stimulants (pemoline), and the novel wake-promoting agent modafinil.

Từ khóa


Tài liệu tham khảo

10.1212/WNL.42.8.1468

10.1017/S0317167100026603

10.1002/ana.410390405

10.1177/135245850000600308

Freal JE, 1984, Arch Phys Med Rehabil, 65, 135

10.1017/S0317167100047107

10.1001/archneur.1988.00520280085020

Bergamaschi R, 1997, Funct Neurol, 12, 247

10.1017/S0317167100048691

10.1016/S0003-9993(96)90162-8

10.1016/0895-4356(95)00027-5

10.1097/00005768-199704000-00014

10.1002/mus.880171006

10.1097/00019052-199612000-00011

10.1016/S0022-510X(02)00312-X

10.1001/archneur.1989.00520460115022

Multiple Sclerosis Clinical Practice Guideline, 1999, Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis

10.1177/135245859900500103

10.1212/WNL.45.11.1956

10.1212/WNL.53.4.743

10.1212/WNL.55.7.934

10.1001/archneur.1989.00520420096030

10.1111/jon199884228

10.1212/WNL.48.6.1566

10.1001/archneur.58.5.742

10.1001/archneur.59.1.62

10.1097/00001756-200303030-00008

10.1212/WNL.53.5.1151

10.1007/s004150050382

10.1056/NEJM198206243062505

10.1111/j.1749-6632.1995.tb44522.x

10.1093/brain/120.2.299

Paty DW, 1998, Multiple sclerosis, 48

10.1016/S0022-510X(00)00411-1

10.1212/WNL.43.10.2016

10.1136/jnnp.52.8.940

10.1212/WNL.46.3.632

10.1002/(SICI)1097-4598(199808)21:8<1068::AID-MUS12>3.0.CO;2-Q

10.2165/00007256-199927030-00004

10.1136/jnnp.72.2.179

10.1073/pnas.93.24.14128

10.1523/JNEUROSCI.20-22-08620.2000

10.1212/WNL.54.5.1166

10.1111/j.1365-2869.1995.tb00172.x

10.1159/000196661

10.4088/JCP.v61n0510

Thông tin
Thông tin xuất bản

Multiple Sclerosis Journal

Tập 9 Số 3

219-227

Thông tin tác giả